Diffuse Large B-Cell Breast Lymphoma: A Case Series

Primary breast lymphoma (PBL) is a rare disease, and few clinicohistopathologic features of the disease have been discussed in previous studies. It represents 2.2% of extranodal lymphomas and constitutes 0.04% to 0.5% of malignant breast neoplasms, despite the clinical and radiographic similarities...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Battah, Afaf H, Al Kuwari, Einas A, Hascsi, Zsolt, Nashwan, Abdulqadir J, Elomari, Halima, Elsabah, Hisham, Al Azawi, Safa, Kohla, Samah, Soliman, Dina, Yassin, Mohamed A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560510/
https://www.ncbi.nlm.nih.gov/pubmed/28839450
http://dx.doi.org/10.1177/1179545X17725034
Descripción
Sumario:Primary breast lymphoma (PBL) is a rare disease, and few clinicohistopathologic features of the disease have been discussed in previous studies. It represents 2.2% of extranodal lymphomas and constitutes 0.04% to 0.5% of malignant breast neoplasms, despite the clinical and radiographic similarities between breast lymphoma and carcinoma, the prognosis, as reported in the literature, varies. No consensus exists on the best way to treat PBL. However, radiotherapy and chemotherapy were used alone or in combination to treat various cases of PBL. We retrospectively studied 3 cases of PBL of the breast seen in patients attending a tertiary cancer center in Qatar, between 2012 and 2015, in an attempt to determine the common clinical features, therapy, and prognosis of PBL.

Ejemplares similares